Inari Medical, Inc.

    Inari Medical, Inc.

    NNASDAQ:NARI
    - -
    USD
    - -
    - -
    Inari Medical, Inc.
    NASDAQ:NARI
    (Nasdaq Stock Market)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    USD
    0.18
    1.33
    4.36
    5.56
    7.26
    8.7
    9.88
    Revenue per Share
    -0.26
    -0.03
    0.43
    0.2
    -0.55
    -0.03
    -1.35
    Basic EPS, GAAP
    -0.3
    -0.21
    -0.11
    0.24
    -0.45
    0.55
    0.09
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -1.05
    -1.07
    -0.85
    -0.35
    -0.89
    -0.85
    -2.1
    Book Value per Share
    -1.03
    -1.02
    6.25
    4.8
    7.89
    1.76
    1.33
    Tangible Book Value per Share
    38
    38
    32
    50
    53
    57
    58
    Basic Weighted Avg Shares
    7
    51
    140
    277
    383
    494
    574
    Sales/Revenue/Turnover
    -133.84
    1.57
    13.19
    3.92
    -7.33
    -2.84
    -6.92
    Operating Margin (%)
    - -
    1
    1
    4
    7
    11
    18
    Depreciation Expense
    -10
    -1
    14
    10
    -29
    -2
    -79
    Net Income, GAAP
    - -
    - -
    - -
    7.91
    - -
    138.53
    - -
    Effective Tax Rate (%)
    -148.67
    -2.33
    9.87
    3.55
    -7.63
    -0.33
    -13.68
    Profit Margin (%)
    24
    31
    192
    203
    367
    159
    115
    Working Capital
    10
    19
    - -
    28
    31
    30
    31
    LT Debt
    -39
    -39
    200
    239
    417
    465
    435
    Total Equity
    - -
    - -
    20.41
    4.26
    - -
    1.15
    - -
    Return on Invested Capital (%)
    - -
    - -
    -60.79
    -128.8
    - -
    11.08
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    2
    2
    2
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    30
    31
    31
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    58
    58
    58
    Market Capitalization
    2,759
    2,784
    2,398

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    233
    249
    263
    Cash, Cash Equivalents & STI
    101
    110
    112
    Accounts Receivable, Net
    79
    81
    83
    Inventories
    45
    49
    55
    Total Current Liabilities
    86
    138
    149
    Payables & Accruals
    84
    136
    147
    ST Debt
    2
    2
    2
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -101.41%
    11.49%
    Free Cash Flow
    - -
    -210.59%
    -230.49%
    Net Income, GAAP
    - -
    -373.11%
    -94.41%
    Sales/Revenue/Turnover
    - -
    197.47%
    28.73%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    87
    93
    96
    108
    383
    2023
    116
    119
    126
    132
    494
    2024
    143
    146
    153
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.06
    -0.19
    -0.19
    -0.11
    -0.55
    2023
    -0.04
    0.04
    0.06
    - -
    -0.03
    2024
    -0.42
    -0.54
    -0.31
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • marketbeat.com

      If You Could Only Hold 3 Investments for Life, Consider These

    • globenewswire.com

      Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Shareholders to Connect

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Shareholders to Learn More About the Investigation

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Investors to Learn More About the Investigation

    • accessnewswire.com

      Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation

    • zacks.com

      Reasons to Retain Inari Medical Stock in Your Portfolio for Now

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Stockholders to Reach Out

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Stockholders to Connect

    • accessnewswire.com

      Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out

    • accessnewswire.com

      Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Shareholders to Learn More About the Investigation

    • accessnewswire.com

      Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

    • zacks.com

      Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice